Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab169299-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$49.90
|
|
|
Ab169299-1mg
|
1mg |
5
|
$207.90
|
|
|
Ab169299-5mg
|
5mg |
1
|
$597.90
|
|
|
Ab169299-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,017.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Spartalizumab (anti-PD-1) - Primary antibody, for ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt various applications, specific to PDCD1, >95%, high purity, Human IgG4SP, Antibody of programmed cell death 1 (CD279) |
|---|---|
| Synonyms | hPD-1 | Protein PD-1 |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | PDCD1 |
| Application | ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR),Flow Cyt |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | ANTAGONIST |
| Mechanism of action | Antibody of programmed cell death 1 (CD279) |
| Product Description |
Spartalizumab is a humanized immunoglobulin 4 monoclonal antibody that binds to PD-1 with subanomolar activity and blocks interactions with PD-L1 and PD-L2. Spartalizumab can be used in the study of thyroid undifferentiated carcinoma (ATC). Purity >95% (SDS-PAGE&SEC) Endotoxin Level < 1.0EU/mg |
| Antibody Type | Primary antibody |
|---|---|
| Clonality | Recombinant |
| Isotype | Human IgG4SP |
| Light Chain Type | kappa |
| SDS-PAGE | 28.1 kDa (Light Chain) & 51.7 kDa (Heavy Chain), under reducing conditions; 175.9 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Purity | >95% |
| Source | CHO supernatant |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 1935694-88-4 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Spartalizumab (anti-PD-1) (Ab169299) - ELISA
Immobilized Recombinant Human PD-1 Protein at 1 μg/mL can bind Spartalizumab (anti-PD-1) (Ab169299) with the EC₅₀ of 39.7 ng/mL.
Spartalizumab (anti-PD-1) (Ab169299) - SEC
The purity of Spartalizumab (anti-PD-1) (Ab169299) is more than 95% verified by HPLC.
Spartalizumab (anti-PD-1) (Ab169299) - ELISA
Immobilized Recombinant Human PD-1 Protein (rp176241) at 1.0 μg/mL can bind Spartalizumab (anti-PD-1) (Ab169299) with the EC50 of 13.27 ng/mL.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Dec 13, 2023 | Ab169299 | |
| Certificate of Analysis | Dec 13, 2023 | Ab169299 |
Starting at $109.90
Starting at $109.90
Starting at $29.90
Starting at $69.90
Starting at $109.90
Starting at $49.90
Starting at $109.90
Starting at $59.90
Starting at $69.90
Starting at $109.90
Starting at $89.90
Starting at $89.90
Starting at $59.90
Starting at $69.90
Starting at $89.90
Starting at $109.90